Form 4 for SER Serina Therapeutics, Inc.
Accepted 2024-05-24 00:00:00 ET · period of report 2024-05-21 · accession 0001493152-24-021358 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-24 | 2024-05-21+ | SER | Bailey Gregory | Dir | P - Purchase | $9.50 | +3,287 | 4,809 | +216% | +$31.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-21 | P | A | 916 | $9.50 | 2,438 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-23 | P | A | 2,371 | $9.50 | 4,809 | D | — | — |